AUPP263498A0 - Novel therapeutic molecules and uses therefor - Google Patents

Novel therapeutic molecules and uses therefor

Info

Publication number
AUPP263498A0
AUPP263498A0 AUPP2634A AUPP263498A AUPP263498A0 AU PP263498 A0 AUPP263498 A0 AU PP263498A0 AU PP2634 A AUPP2634 A AU PP2634A AU PP263498 A AUPP263498 A AU PP263498A AU PP263498 A0 AUPP263498 A0 AU PP263498A0
Authority
AU
Australia
Prior art keywords
novel therapeutic
therapeutic molecules
uses therefor
therefor
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP2634A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Priority to AUPP2634A priority Critical patent/AUPP263498A0/en
Publication of AUPP263498A0 publication Critical patent/AUPP263498A0/en
Priority to EP99912974A priority patent/EP1064374A1/en
Priority to AU31277/99A priority patent/AU3127799A/en
Priority to PCT/AU1999/000220 priority patent/WO1999050410A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716Muscle proteins, e.g. myosin, actin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AUPP2634A 1998-03-27 1998-03-27 Novel therapeutic molecules and uses therefor Abandoned AUPP263498A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AUPP2634A AUPP263498A0 (en) 1998-03-27 1998-03-27 Novel therapeutic molecules and uses therefor
EP99912974A EP1064374A1 (en) 1998-03-27 1999-03-26 Novel molecules expressed during muscle development and genetic sequences encoding the same
AU31277/99A AU3127799A (en) 1998-03-27 1999-03-26 Novel molecules expressed during muscle development and genetic sequences encoding the same
PCT/AU1999/000220 WO1999050410A1 (en) 1998-03-27 1999-03-26 Novel molecules expressed during muscle development and genetic sequences encoding the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP2634A AUPP263498A0 (en) 1998-03-27 1998-03-27 Novel therapeutic molecules and uses therefor

Publications (1)

Publication Number Publication Date
AUPP263498A0 true AUPP263498A0 (en) 1998-04-23

Family

ID=3806895

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP2634A Abandoned AUPP263498A0 (en) 1998-03-27 1998-03-27 Novel therapeutic molecules and uses therefor

Country Status (3)

Country Link
EP (1) EP1064374A1 (en)
AU (1) AUPP263498A0 (en)
WO (1) WO1999050410A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003534809A (en) * 2000-05-30 2003-11-25 メディジェーン アクチェンゲゼルシャフト Novel target genes for heart disease
AU2001268570A1 (en) * 2000-06-16 2001-12-24 Millennium Pharmaceuticals, Inc. 33358, a novel human ankyrin family member and uses thereof
US7629308B2 (en) 2000-07-07 2009-12-08 Board Of Regents, The University Of Texas System Methods relating to muscle selective calcineurin interacting protein (MCIP)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
US4876197A (en) * 1983-02-22 1989-10-24 Chiron Corporation Eukaryotic regulatable transcription
US4880734A (en) * 1984-05-11 1989-11-14 Chiron Corporation Eukaryotic regulatable transcription
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor
WO1995020975A1 (en) * 1994-02-04 1995-08-10 The Regents Of The University Of California Tef-1 isoforms and uses thereof

Also Published As

Publication number Publication date
EP1064374A1 (en) 2001-01-03
WO1999050410A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
AU2113599A (en) Human protease molecules
EP1015578A4 (en) Therapeutic molecules
AU9403798A (en) Human regulatory molecules
AU1184399A (en) Therapeutic molecules
EP1147213A4 (en) Novel rgs-containing molecules and uses thereof
AU5320700A (en) Novel toll molecules and uses therefor
AU2587399A (en) Human transport-associated molecules
AU4629399A (en) Substituted piperazones and their therapeutic uses
AUPP263498A0 (en) Novel therapeutic molecules and uses therefor
AUPM885894A0 (en) Therapeutic molecules
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
AU2591099A (en) Human proteinase molecules
AUPP551298A0 (en) Novel therapeutic molecules and uses therefor
AU5611799A (en) Novel therapeutic molecules and uses therefor
AUPP625298A0 (en) Novel therapeutic molecules and uses therefor - II
AUPP798698A0 (en) Novel therapeutic molecules and methods relating thereto
AU5005099A (en) Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof
AUPQ150499A0 (en) Novel therapeutic molecules and uses thereof-II
AUPP573398A0 (en) Therapeutic molecules and methods
AUPQ033999A0 (en) Novel therapeutic molecules and uses thereof
AUPQ158499A0 (en) Therapeutic molecules and methods-ii
AUPQ157499A0 (en) Therapeutic molecules and methods-iii
AUPO926397A0 (en) Novel therapeutic molecules
AUPP096197A0 (en) Novel molecules and uses thereof-iv
AUPO896397A0 (en) Novel molecules and uses thereof-iii